List view / Grid view
Dr Sheraz Gul, Head of Assay Development and Screening at…
Dr Sheraz Gul, Head of Assay Development and Screening at the Fraunhofer Institute for Molecular Biology and Applied Ecology, answers questions on assay procedures...
Featured in this Stem Cells In-depth Focus: Translating stem cell…
Featured in this Stem Cells In-depth Focus: Translating stem cell biology into drug discovery; Mechanism-informed phenotypic screening – the missing link for cancer drug discovery; Analysis of human stem cell interactions at the single-cell resolution...
Preview of the upcoming foreword in our April issue, written…
Preview of the upcoming foreword in our April issue, written by Sheraz Gul, Vice President and Head of Biology at Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Hamburg, Germany...
Sheraz Gul, Head of Biology at Fraunhofer-IME SP, provides an…
Sheraz Gul, Head of Biology at Fraunhofer-IME SP, provides an in-depth review of the Cell-Based Assays for Screening workshop which took place in December 2014...
Editor Caroline Richards talks about the editorial board members who…
Editor Caroline Richards talks about the editorial board members who have influenced the content coming up in the latest issue of Drug Target Review, available in April 2015...
Head of Drug Discovery at the Fraunhofer Institute for Molecular…
6 February 2015 | By
Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology
Despite the ever increasing efforts being expended for drug discovery…
Despite the ever increasing efforts being expended for drug discovery purposes, the number of approved drugs remains relatively static. A variety of explanations have been provided to explain this observation and initiatives to remedy this situation have been implemented. Many of these initiatives are still works-in-progress and whether these will…
